Medirom Healthcare Technologies (MRM) Cash & Equivalents (2020 - 2025)

Medirom Healthcare Technologies has reported Cash & Equivalents for 6 years, with the latest figure at $2.3 million in Q2 2025.

• For the quarter ending Q2 2025, Cash & Equivalents rose 233.23% year-over-year to $2.3 million; the trailing twelve-month figure through Jun 2025 stood at $2.3 million (up 233.23% YoY), and the FY2024 full-year result was $2.2 million, up 186.98% from the prior year.
• Cash & Equivalents for Q2 2025 stood at $2.3 million, up from $2.2 million in the prior quarter.
• The five-year high for Cash & Equivalents was $13.2 million in Q2 2021, with the low at $683162.4 in Q2 2024.
• Average Cash & Equivalents over 5 years is $4.0 million, with a median of $2.7 million recorded in 2022.
• Year-over-year, Cash & Equivalents slumped 84.54% in 2024 and jumped 233.23% in 2025.
• Tracing MRM's Cash & Equivalents over 5 years: stood at $13.2 million in 2021, then sank by 80.05% to $2.6 million in 2022, then surged by 56.14% to $4.1 million in 2023, then slumped by 47.1% to $2.2 million in 2024, then rose by 5.07% to $2.3 million in 2025.
• The last three Cash & Equivalents figures came in at $2.3 million (Q2 2025), $2.2 million (Q4 2024), and $683162.4 (Q2 2024), per Business Quant data.

Peer Comparison